Methylation-Sensitive Cas9 Cleavage for Epigenetic DNA Recognition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current CRISPR-Cas9 systems do not recognize cytosine methylation patterns, limiting their ability to harness epigenetic information for precise genome editing and disease detection.
Innovation Solution
Development of methylation-sensitive Cas9 molecules, such as ThermoCas9, which cleave nucleic acids differently based on the presence of methylated cytosine residues within the protospacer adjacent motif (PAM) recognition sequence.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If standard Cas9 molecules are used for genome editing, then cleavage activity is maintained, but ability to recognize methylation patterns is lost
Solution Approach 1:
The patent introduces point mutations at specific positions (e.g., R679Q, R1063Q) within the Cas9 molecule to create localized changes in the PAM recognition domain. These localized modifications enable methylation sensitivity while preserving overall cleavage function, allowing the Cas9 molecule to differentiate between methylated and unmethylated DNA at specific sites without losing general activity.
Solution Approach 2:
The invention alters the biochemical parameters of the Cas9 molecule by introducing amino acid substitutions that change its interaction with methylated cytosine residues. These parameter changes transform the Cas9 from a standard cleavage enzyme to one that can discriminate based on epigenetic marks, enabling methylation-dependent recognition while maintaining catalytic function.
2Adaptability or versatility
If Cas9 is engineered to recognize methylation patterns, then epigenetic detection capability is improved, but molecular complexity increases
Solution Approach 1:
Rather than globally redesigning the Cas9 molecule, the patent applies targeted point mutations at specific positions within the PAM recognition domain. This localized approach adds epigenetic recognition capability with minimal structural changes, avoiding the complexity that would arise from comprehensive reengineering of the entire Cas9 architecture.
Solution Approach 2:
The engineered Cas9 molecules maintain their universal genome editing function while acquiring an additional epigenetic recognition function. The same Cas9 molecule can perform both standard DNA cleavage and methylation-pattern recognition, eliminating the need for separate detection systems and reducing overall system complexity.
3Measurement precision
If methylation-sensitive Cas9 is developed, then disease detection precision is improved, but development difficulty increases
Solution Approach 1:
The patent achieves methylation sensitivity through straightforward amino acid substitutions (e.g., R679Q, R1063Q) that alter the electrostatic properties of the PAM recognition domain. These parameter changes are implemented through standard molecular cloning techniques, making the engineering process accessible and reproducible without requiring complex synthetic biology approaches.
Solution Approach 2:
The invention creates multiple variants of methylation-sensitive Cas9 by copying and adapting successful mutation patterns from initial experiments. Once a functional mutation pattern is established, it can be replicated and tested across different Cas9 orthologs and target sequences, streamlining the development process and reducing overall engineering difficulty.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise epigenetic editing and disease detection by recognizing and responding to methylation changes, allowing for targeted gene modification and diagnostic applications.
Implementation Method 1
a target nucleic acid molecule comprises a protospacer adjacent motif (PAM) recognition sequence which is recognized by the Cas9 molecule
Implementation Method 2
the Cas9 molecule cleaves the target nucleic acid at a cleavage site differently upon presence of a methylated cytosine residue within the PAM recognition sequence compared to a non-methylated version of the same cytosine residue
Implementation Method 3
Cytosine methylation (5° C.) and its dynamic counterpart, demethylation, are hallmarks of gene regulation in animals and plants
Data Source
AI summary
Certain Cas9 molecules are capable of discriminately cleaving nucleic acid based upon its epigenetic pattern. These molecules can be either naturally occurring or engineered. They can be used to diagnose and treat disease.